A share price of Edgewise Therapeutics Inc [EWTX] is currently trading at $27.52, up 8.65%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The EWTX shares have gain 3.61% over the last week, with a monthly amount drifted -7.65%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Edgewise Therapeutics Inc [NASDAQ: EWTX] stock has seen the most recent analyst activity on November 22, 2024, when Evercore ISI initiated its Outperform rating and assigned the stock a price target of $45. Previously, Piper Sandler started tracking the stock with Overweight rating on March 07, 2024, and set its price target to $48. On May 01, 2023, Truist initiated with a Buy rating. Goldman downgraded its rating to a Sell but stick to its price target of $5 on August 25, 2022. RBC Capital Mkts initiated its recommendation with a Outperform and recommended $31 as its price target on April 13, 2022. Goldman started tracking with a Neutral rating for this stock on January 28, 2022, and assigned it a price target of $11.
Edgewise Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $9.00 and $38.12. Currently, Wall Street analysts expect the stock to reach $46.25 within the next 12 months. Edgewise Therapeutics Inc [NASDAQ: EWTX] shares were valued at $27.52 at the most recent close of the market. An investor can expect a potential return of 68.06% based on the average EWTX price forecast.
Analyzing the EWTX fundamentals
Gross Profit Margin for this corporation currently stands at 0.29% with Operating Profit Margin at -65.34%, Pretax Profit Margin comes in at -55.19%, and Net Profit Margin reading is -55.19%. To continue investigating profitability, this company’s Return on Assets is posted at -0.24, Equity is -0.27 and Total Capital is -0.3. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 25.65 points at the first support level, and at 23.77 for the second support level. However, for the 1st resistance point, the stock is sitting at 28.70, and for the 2nd resistance point, it is at 29.87.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Edgewise Therapeutics Inc [NASDAQ:EWTX] is 26.35. Further, the Quick Ratio stands at 26.35, while the Cash Ratio is 2.36.
Transactions by insiders
Recent insider trading involved Russell Alan J, Chief Scientific Officer, that happened on Dec 30 ’24 when 100000.0 shares were sold. Director, ALAN J RUSSELL completed a deal on Dec 30 ’24 to buy 100000.0 shares. Meanwhile, Chief Development Officer Semigran Marc sold 29709.0 shares on Dec 24 ’24.
